Eric P. Lefkofsky Sells 82,056 Shares of Tempus AI, Inc. (NASDAQ:TEM) Stock

Tempus AI, Inc. (NASDAQ:TEM - Get Free Report) CEO Eric P. Lefkofsky sold 82,056 shares of the business's stock in a transaction dated Friday, January 31st. The shares were sold at an average price of $58.21, for a total value of $4,776,479.76. Following the completion of the sale, the chief executive officer now owns 5,532,987 shares in the company, valued at $322,075,173.27. This represents a 1.46 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which can be accessed through this link.

Tempus AI Trading Up 5.4 %

Shares of NASDAQ TEM traded up $3.11 during midday trading on Monday, reaching $60.50. The stock had a trading volume of 12,490,292 shares, compared to its average volume of 10,412,109. The company has a debt-to-equity ratio of 8.17, a quick ratio of 2.55 and a current ratio of 2.69. The stock has a 50-day moving average of $44.18 and a 200-day moving average of $48.29. Tempus AI, Inc. has a 12-month low of $22.89 and a 12-month high of $79.49.

Wall Street Analysts Forecast Growth

Several analysts have weighed in on TEM shares. Wolfe Research assumed coverage on Tempus AI in a report on Friday, December 13th. They issued an "outperform" rating and a $60.00 price target on the stock. Bank of America increased their price target on shares of Tempus AI from $52.00 to $54.00 and gave the company a "neutral" rating in a research report on Friday, December 13th. Stifel Nicolaus cut shares of Tempus AI from a "buy" rating to a "hold" rating and upped their price objective for the company from $45.00 to $65.00 in a research note on Monday, November 11th. Loop Capital decreased their target price on shares of Tempus AI from $57.00 to $52.00 and set a "buy" rating on the stock in a research report on Tuesday, January 14th. Finally, Guggenheim assumed coverage on shares of Tempus AI in a research report on Monday, December 9th. They set a "buy" rating and a $74.00 price target for the company. Three analysts have rated the stock with a hold rating and nine have issued a buy rating to the company. According to MarketBeat, Tempus AI has a consensus rating of "Moderate Buy" and a consensus price target of $56.36.

Institutional Inflows and Outflows

Several hedge funds and other institutional investors have recently made changes to their positions in the stock. First Horizon Advisors Inc. bought a new position in shares of Tempus AI in the 3rd quarter valued at about $30,000. FNY Investment Advisers LLC bought a new stake in Tempus AI in the fourth quarter worth $67,000. Vestor Capital LLC purchased a new position in Tempus AI during the third quarter worth $153,000. Mirae Asset Global Investments Co. Ltd. purchased a new stake in shares of Tempus AI in the fourth quarter valued at $178,000. Finally, Stifel Financial Corp purchased a new position in shares of Tempus AI during the 3rd quarter worth about $218,000. Institutional investors own 24.22% of the company's stock.

Tempus AI Company Profile

Tempus AI Inc is a technology company advancing precision medicine through the practical application of artificial intelligence principally in healthcare. The company provides AI-enabled precision medicine solutions to physicians to deliver personalized patient care and in parallel facilitates discovery, development and delivery of optimal therapeutics.